91 related articles for article (PubMed ID: 23553733)
1. Reply: To PMID 22610885.
Falleti E; Fabris C; Toniutto P
Hepatology; 2013 Nov; 58(5):1864-5. PubMed ID: 23553733
[No Abstract] [Full Text] [Related]
2. Vitamin D-binding protein gene polymorphisms may contribute to the racial disparity in genotype 1 chronic hepatitis C treatment outcome.
Weintraub SJ; Fleckenstein JF; Marion TN; Madey MA
Hepatology; 2013 Nov; 58(5):1864. PubMed ID: 23553666
[No Abstract] [Full Text] [Related]
3. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
[TBL] [Abstract][Full Text] [Related]
4. Reply: To PMID 24975775.
Pineda-Tenor D; García-Álvarez M; Jiménez-Sousa MA; Fernández-Rodríguez A; Resino S
Hepatology; 2015 Nov; 62(5):1643. PubMed ID: 25807876
[No Abstract] [Full Text] [Related]
5. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients.
Baur K; Mertens JC; Schmitt J; Iwata R; Stieger B; Frei P; Seifert B; Bischoff Ferrari HA; von Eckardstein A; Müllhaupt B; Geier A;
Antivir Ther; 2012; 17(3):541-7. PubMed ID: 22300961
[TBL] [Abstract][Full Text] [Related]
6. Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/ribavirin-based therapy in Egyptian patients with chronic hepatitis C.
Abdelsalam A; Rashed L; Salman T; Hammad L; Sabry D
J Dig Dis; 2016 Aug; 17(8):547-553. PubMed ID: 27128845
[TBL] [Abstract][Full Text] [Related]
7. Reply: To PMID 24691835.
Petta S; Cabibbo G; Cammà C
Hepatology; 2015 Mar; 61(3):1097. PubMed ID: 25043351
[No Abstract] [Full Text] [Related]
8. Relationship between vitamin D status and response to hepatitis C virus therapy.
Kitson MT; Sarrazin C; Toniutto P; Roberts SK
Hepatology; 2015 Nov; 62(5):1642-3. PubMed ID: 25808060
[No Abstract] [Full Text] [Related]
9. Reply: To PMID 23564522.
Asahina Y; Tsuchiya K; Izumi N
Hepatology; 2014 Aug; 60(2):764. PubMed ID: 24519221
[No Abstract] [Full Text] [Related]
10. Reply: To PMID 24126097.
Afdhal NH; Theodore D
Gastroenterology; 2014 Jul; 147(1):255-6. PubMed ID: 24877870
[No Abstract] [Full Text] [Related]
11. [Possibilities of triple antiviral therapy in chronic hepatitis C].
Golovanova EV
Eksp Klin Gastroenterol; 2012; (6):86-95. PubMed ID: 23402197
[No Abstract] [Full Text] [Related]
12. Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.
Bitetto D; Fabris C; Fornasiere E; Pipan C; Fumolo E; Cussigh A; Bignulin S; Cmet S; Fontanini E; Falleti E; Martinella R; Pirisi M; Toniutto P
Transpl Int; 2011 Jan; 24(1):43-50. PubMed ID: 20649944
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.
Tang J; Kaslow RA
Pharmacogenomics J; 2004; 4(3):171-4. PubMed ID: 15069460
[No Abstract] [Full Text] [Related]
14. Chronic hepatitis C genotype 2 or 3 short treatment.
Moreno-Otero R; Trapero M; Moreno-Monteagudo JA
Hepatology; 2008 May; 47(5):1796. PubMed ID: 18438810
[No Abstract] [Full Text] [Related]
15. An update on treatment of hepatitis C virus genotype 1 infection and viral load assessments.
Cobb B; Vilchez RA
Hepatology; 2012 Mar; 55(3):979-80; author reply 980-1. PubMed ID: 22161994
[No Abstract] [Full Text] [Related]
16. Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.
Loftfield E; O'Brien TR; Pfeiffer RM; Howell CD; Horst R; Prokunina-Olsson L; Weinstein SJ; Albanes D; Morgan TR; Freedman ND
PLoS One; 2016; 11(11):e0166036. PubMed ID: 27832143
[TBL] [Abstract][Full Text] [Related]
17. Chronic genotype 4 hepatitis C.
Schafer DF
Hepatology; 2008 May; 47(5):1791-2; author reply 1793-4. PubMed ID: 18395844
[No Abstract] [Full Text] [Related]
18. Reply to: "Evidence supporting a beneficial role of vitamin D in chronic hepatitis C".
Kitson MT; Sarrazin C; Toniutto P; Roberts SK
J Hepatol; 2015 Aug; 63(2):531-2. PubMed ID: 25899534
[No Abstract] [Full Text] [Related]
19. [Virological monitoring of hepatitis C treatment in 2009].
Cacoub P; Halfon P
Rev Med Interne; 2009 Oct; 30(10):838-40. PubMed ID: 19525041
[No Abstract] [Full Text] [Related]
20. [Chronic hepatitis C. Something new].
Sabourin G
Perspect Infirm; 2015; 12(1):60. PubMed ID: 25651685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
